University of Western Ontario, London, ON.
J Cutan Med Surg. 2010 Jul-Aug;14(4):156-60. doi: 10.2310/7750.2010.09037.
scarring is an important component of overall acne severity, but there are no global scales for its evaluation inclusive of the face and trunk.
our objective was to develop a global scale for acne scar severity inclusive of the trunk and the face.
a six-category global severity scale (SCAR-S) was developed for assessment of acne scarring at each of the face, chest, and back. We evaluated SCAR-S against acne severity and patient-reported scar severity.
of 973 subjects, 73% reported acne scarring. Self-assessment of scarring was associated with facial SCAR-S and overall SCAR-S scores (p < .001, r = .31 and .30, respectively). Acne scarring was observed at the face in 87%, the back in 51%, and the chest in 38%. Clinically relevant scarring (mild or greater) at each of these regions was 55%, 24%, and 14%, respectively. Acne severity correlated with SCAR-S (p < .001) for the back (r = .612), the chest (r = .548), and the face (r = .514). Acne duration correlated with patient-reported severity of scarring (r = .244) and overall SCAR-S scores (r = .152). Clinically relevant scarring increased with acne duration.
SCAR-S is a practical, validated, global system for acne scar evaluation and is clinically relevant in overall severity grading of acne.
疤痕是痤疮严重程度的一个重要组成部分,但目前还没有一种全面的评估痤疮疤痕严重程度的全球量表,包括面部和躯干。
我们旨在开发一种包括面部和躯干的痤疮疤痕严重程度的全球量表。
我们开发了一种六类全球严重程度量表(SCAR-S),用于评估面部、胸部和背部的痤疮疤痕。我们评估了 SCAR-S 与痤疮严重程度和患者报告的疤痕严重程度之间的相关性。
在 973 名受试者中,73%报告有痤疮疤痕。自我评估的疤痕与面部 SCAR-S 和总体 SCAR-S 评分相关(p <.001,r =.31 和.30)。痤疮疤痕在面部、背部和胸部的发生率分别为 87%、51%和 38%。这些部位的每个部位的临床相关疤痕(轻度或更严重)发生率分别为 55%、24%和 14%。痤疮严重程度与 SCAR-S 评分相关(p <.001),背部(r =.612)、胸部(r =.548)和面部(r =.514)。痤疮持续时间与患者报告的疤痕严重程度(r =.244)和总体 SCAR-S 评分(r =.152)相关。随着痤疮持续时间的延长,临床相关疤痕的发生率增加。
SCAR-S 是一种实用的、经过验证的、用于评估痤疮疤痕的全球系统,在评估痤疮的总体严重程度方面具有临床相关性。